ASTRAZEN Intraday Analysis...

ASTRAZEN Share Price

Open 959.05 Change Price %
High 972.00 1 Day 10.05 1.05
Low 947.95 1 Week 4.25 0.44
Close 968.85 1 Month 15.90 1.67
Volume 2882 1 Year -180.40 -15.70
52 Week High 1314.90
52 Week Low 909.70
ASTRAZEN Important Levels
Resistance 2 991.14
Resistance 1 981.96
Pivot 962.93
Support 1 955.74
Support 2 946.56
NSE INDIA Most Active Stocks
JPASSOCIAT 10.20 5.15%
SUZLON 15.70 0.64%
JINDALSTEL 80.20 3.48%
ADANIPOWER 37.85 2.30%
HINDALCO 177.00 3.48%
VEDL 244.40 3.52%
GMRINFRA 12.55 0.00%
BHEL 132.40 3.48%
POWERGRID 198.45 0.35%
NHPC 29.80 -0.50%
More..
NSE INDIA Top Gainers Stocks
RASOYPR 0.20 33.33%
FMNL 45.00 20.00%
INDOTHAI 25.05 19.86%
HOTELRUGBY 4.60 19.48%
OILCOUNTUB 52.05 17.89%
PANACEABIO 148.30 16.59%
ELGIRUBCO 55.95 15.96%
TRIL 437.90 15.42%
WEIZFOREX 244.90 14.81%
JINDCOT 16.85 14.63%
More..
NSE INDIA Top Losers Stocks
VKSPL 0.10 -33.33%
FCSSOFT 0.30 -14.29%
SPYL 1.00 -13.04%
NAKODA 0.40 -11.11%
UNITEDTEA 303.95 -8.55%
AGARIND 332.80 -7.14%
ASIL 0.70 -6.67%
CELESTIAL 21.30 -6.17%
KRIDHANINF 57.75 -6.02%
SUNDARAM 4.05 -5.81%
More..

AstraZeneca Pharma India Limited (NSE: ASTRAZEN)

ASTRAZEN Technical Analysis 2
As on 18th Jan 2017 ASTRAZEN Share Price closed @ 968.85 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1050.96 & Buy for SHORT-TERM with Stoploss of 952.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
ASTRAZEN Target for January
1st Target up-side 967.77
2nd Target up-side 996.84
3rd Target up-side 1025.91
1st Target down-side 884.83
2nd Target down-side 855.76
3rd Target down-side 826.69
ASTRAZEN Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
ASTRAZEN Other Details
Segment EQ
Market Capital 1830661632.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.astrazenecaindia.com
ASTRAZEN Address
ASTRAZEN
Avishkar
Post box No. 2483
Bengaluru, 560024
India
Phone: 91 80 6774 8000
Fax: 91 80 2362 2015
ASTRAZEN Latest News
AstraZeneca Pharma India Limited   Moneycontrol.com   - 06th Feb 15
Update for AstraZeneca Pharma India Ltd   Hindu Business Line   - 27th Nov 14
Bombay High Court stays delisting proposal of AstraZeneca Pharma   pharmabiz.com   - 10th Oct 14
HC stays proposed delisting of AstraZeneca Pharma   Livemint   - 09th Oct 14
AstraZeneca delisting plan faces opposition   Livemint   - 14th Jul 14
Astrazeneca Pharma India falls; SEBI says exchanges to monitor delisting   Reuters   - 25th Jun 14
Delisting: Will AstraZeneca be third time lucky?   Hindu Business Line   - 20th Mar 14
AstraZeneca Pharma India board approves delisting offer   VC Circle   - 18th Mar 14
Astrazeneca Pharma India surges on delisting proposal   Reuters   - 03rd Mar 14
AstraZeneca Pharma promoter to sell stake in Indian arm   Economic Times   - 24th May 13
Interactive Technical Analysis Chart AstraZeneca Pharma India Limited ( ASTRAZEN NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on AstraZeneca Pharma India Limited
ASTRAZEN Business Profile
AstraZeneca is in the Pharmaceuticals sector. AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by 2009 prescription drug sales (after Pfizer, Novartis, Sanofi, and GlaxoSmithKline) and has operations in over 100 countries.It has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. The company was founded in 1999 through the merger of the Sweden-based Astra AB and the UK-based Zeneca Group. AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It had a market capitalisation of approximately £39.5 billion as of 23 December 2011, the tenth-largest of any company with a primary listing on the London Stock Exchange.[7] It has secondary listings on the New York Stock Exchange and the OMX exchange. The current market capitalisation stands at Rs 2,061.75 crore.The company has reported a standalone sales of Rs 115.66 crore and a Net Loss of Rs 1.23 crore for the quarter ended Sep 2013. The company management includes D E Udwadia - Chairman, Sanjay Murdeshwar - Managing Director, Robert Ian Haxton - Whole Time Director, Narayan K Seshadri - Director, Ian Brimicombe - Director. It is listed on the BSE with a BSE Code of 506820 and the NSE with an NSE Code of ASTRAZEN. Its Registered office is at "Avishkar", Off Bellary Road,,Hebbal. Bangalore,Karnataka - 560024.